Home Archive by category Opinion & Analysis (Page 2)

Opinion & Analysis

Opinion & Analysis
MEI Pharma, a Nasdaq-listed pharmaceutical company, has bought 929,548 Litecoin tokens to launch a $100 million institutional treasury strategy. A symmetrical triangle pattern drives the midterm sideways trend in Litecoin price. A potential reversal in LTC could seek pullback support at $105 to recuperate bullish momentum. Litecoin, the decentralized peer-to-peer Continue Reading
Opinion & Analysis
Key highlights: The online performance-based marketing company, SharpLink, has recently accumulated another 18,680 ETH to boost its total holding to 498,711 ETH (worth approximately $1.81 billion). Another institutional address purchased 14,006 ETH ($50 million) from the exchange platform OSL. Since December 2021, the Ethereum price has witnessed a sideways action Continue Reading